Biopsy or not to biopsy...that is the question in this debate between Jaime Landman and Michael Staehler hosted by Monty Pal.  Do we biopsy the small renal mass patient or do we diagnose the patient using exclusively imaging?  The case is made by Jaime to consider why this is the only cancer we do not routinely biopsy.  They discuss why the approach in small renal masses is unique.


Monty Pal and Jaime Landman discuss the value of collaboration with multiple disciplines to effectively manage patients diagnosed with kidney cancer. They provide a historical overview of the treatment of kidney cancer bringing the conversation to revolutionary advances, adding their view on the impact of survival in this patient population.


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.


kidney cancer house ad